Severe preeclampsia: Are hemostatic and inflammatory parameters associated?

Clinica Chimica Acta

Volumn 427, Issue , 2014, Pages 65-70

  Pinheiro, Melina B ^a,b   Carvalho, Maria G ^a   Martins Filho, Olindo A ^c   Freitas, Letícia G ^a   Godoi, Lara C ^a   Alpoim, Patrícia N ^a   Gomes, Karina B ^a   Dusse, Luci M ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO JOÃO DEL REI   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

D Dimer; Inflammatory cytokines; PAI 1; Preeclampsia

Indexed keywords

D DIMER; GAMMA INTERFERON; INTERLEUKIN 6; INTERLEUKIN 8; PLASMINOGEN ACTIVATOR INHIBITOR 1; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; CYTOKINE; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEMOSTASIS; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; PATIENT MONITORING; PREECLAMPSIA; PREGNANT WOMAN; PRIORITY JOURNAL; BLOOD; IMMUNOLOGY; PATHOLOGY; PREGNANCY; YOUNG ADULT;

ADULT; BIOLOGICAL MARKERS; CYTOKINES; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HEMOSTASIS; HUMANS; INFLAMMATION; PLASMINOGEN ACTIVATOR INHIBITOR 1; PRE-ECLAMPSIA; PREGNANCY; YOUNG ADULT;

EID: 84886496363     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2013.09.050     Document Type: Article

References (49)

1. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 2002, 77:67-75.
2. Pennington K.A., Schlitt J.M., Jackson D.L., Schulz L.C., Schust D.J. Preeclampsia: multiple approaches for a multifactorial disease. Dis Model Mech 2012, 5:9-18.
3. He S., Bremme K., Blomback M. Acquired deficiency of antithrombin in association with a hypercoagulable state and impaired function of liver and/or kidney in preeclampsia. Blood Coagul Fibrinolysis 1997, 8:232-238.
4. Ismail S.K., Higgins J.R. Hemostasis in pre-eclampsia. Semin Thromb Hemost 2011, 37:111-117.
5. McKay D.G. Hematologic evidence of disseminated intravascular coagulation in eclampsia. Obstet Gynecol Surv 1972, 27:399-417.
6. Redman C.W., Sargent I.L. Immunology of pre-eclampsia. Am J Reprod Immunol 2010, 63:534-543.
7. Visser N., van Rijn B.B., Rijkers G.T., Franx A., Bruinse H.W. Inflammatory changes in preeclampsia: current understanding of the maternal innate and adaptive immune response. Obstet Gynecol Surv 2007, 62:191-201.
8. Borzychowski A.M., Sargent I.L., Redman C.W. Inflammation and pre-eclampsia. Semin Fetal Neonatal Med 2006, 11:309-316.
9. Roberts J.M. Endothelial dysfunction in preeclampsia. Semin Reprod Endocrinol 1998, 16:5-15.
10. Dusse L.M., Rios D.R., Pinheiro M.B., Cooper A.J., Lwaleed B.A. Pre-eclampsia: relationship between coagulation, fibrinolysis and inflammation. Clin Chim Acta 2011, 412:17-21.
11. Levi M., van der Poll T. Inflammation and coagulation. Crit Care Med 2010, 38:S26-S34.
12. Gaffney P.J. Monoclonal antibodies to crosslinked fibrin degradation products (XL-FDP). Evolution in a variety of clinical conditions. Br J Haematol 1998, 68:91-96.
13. Bellart J., Gilabert R., Fontcuberta J., Carreras E., Miralles R.M., Cabero L. Coagulation and fibrinolytic parameters in normal pregnancy and in pregnancy complicated by intrauterine growth retardation. Am J Perinatol 1998, 15:81-85.
14. Heilmann L., Rath W., Pollow K. Hemostatic abnormalities in patients with severe preeclampsia. Clin Appl Thromb Hemost 2007, 13:285-291.
15. Schjetlein R., Haugen G., Wisloff F. Markers of intravascular coagulation and fibrinolysis in preeclampsia: association with intrauterine growth retardation. Acta Obstet Gynecol Scand 1997, 76:541-546.
16. Terao T., Maki M., Ikenoue T., et al. The relationship between clinical signs and hypercoagulable state in toxemia of pregnancy. Gynecol Obstet Invest 1991, 31:74-85.
17. Catarino C., Rebelo I., Belo L., et al. Relationship between maternal and cord blood hemostatic disturbances in preeclamptic pregnancies. Thromb Res 2008, 123:219-224.
18. Pinheiro MdB, Junqueira D.R., Coelho F.F., et al. D-dimer in preeclampsia: review and meta-analysis. Clin Chim Acta 2012, 23:23.
19. Connaghan D.G., Francis C.W., Lane D.A., Marder V.J. Specific identification of fibrin polymers, fibrinogen degradation products, and crosslinked fibrin degradation products in plasma and serum with a new sensitive technique. Blood 1985, 65:589-597.
20. Estelles A., Gilabert J., Aznar J., Loskutoff D.J., Schleef R.R. Changes in the plasma levels of type 1 and type 2 plasminogen activator inhibitors in normal pregnancy and in patients with severe preeclampsia. Blood 1989, 74:1332-1338.
21. Halligan A., Bonnar J., Sheppard B., Darling M., Walshe J. Haemostatic, fibrinolytic and endothelial variables in normal pregnancies and pre-eclampsia. Br J Obstet Gynaecol 1994, 101:488-492.
22. Estelles A., Gilabert J., Espana F., Aznar J., Galbis M. Fibrinolytic parameters in normotensive pregnancy with intrauterine fetal growth retardation and in severe preeclampsia. Am J Obstet Gynecol 1991, 165:138-142.
23. Oliver J.J., Webb D.J., Newby D.E. Stimulated tissue plasminogen activator release as a marker of endothelial function in humans. Arterioscler Thromb Vasc Biol 2005, 25:2470-2479.
24. Coolman M., de Groot C.J., Steegers E.A., et al. Concentrations of plasminogen activators and their inhibitors in blood preconceptionally, during and after pregnancy. Eur J Obstet Gynecol Reprod Biol 2006, 128:22-28.
25. Robb A.O., Mills N.L., Din J.N., et al. Acute endothelial tissue plasminogen activator release in pregnancy. J Thromb Haemost 2009, 7:138-142.
26. Brown M.A. The physiology of pre-eclampsia. Clin Exp Pharmacol Physiol 1995, 22:781-791.
27. Xie C., Yao M.Z., Liu J.B., Xiong L.K. A meta-analysis of tumor necrosis factor-alpha, interleukin-6, and interleukin-10 in preeclampsia. Cytokine 2011, 56:550-559.
28. Luppi P., Tse H., Lain K.Y., Markovic N., Piganelli J.D., DeLoia J.A. Preeclampsia activates circulating immune cells with engagement of the NF-kappaB pathway. Am J Reprod Immunol 2006, 56:135-144.
29. Conrad K.P., Miles T.M., Benyo D.F. Circulating levels of immunoreactive cytokines in women with preeclampsia. Am J Reprod Immunol 1998, 40:102-111.
30. Kupferminc M.J., Peaceman A.M., Wigton T.R., Tamura R.K., Rehnberg K.A., Socol M.L. Immunoreactive tumor necrosis factor-alpha is elevated in maternal plasma but undetected in amniotic fluid in the second trimester. Am J Obstet Gynecol 1994, 171:976-979.
31. Kauma S., Takacs P., Scordalakes C., Walsh S., Green K., Peng T. Increased endothelial monocyte chemoattractant protein-1 and interleukin-8 in preeclampsia. Obstet Gynecol 2002, 100:706-714.
32. Molvarec A., Szarka A., Walentin S., et al. Serum leptin levels in relation to circulating cytokines, chemokines, adhesion molecules and angiogenic factors in normal pregnancy and preeclampsia. Reprod Biol Endocrinol 2011, 9:124.
33. Szarka A., Rigo J., Lazar L., Beko G., Molvarec A. Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array. BMC Immunol 2010, 11:59.
34. Mansouri R., Akbari F., Vodjgani M., Mahboudi F., Kalantar F., Mirahmadian M. Serum cytokines profiles in Iranian patients with preeclampsia. Iran J Immunol 2007, 4:179-185.
35. Sharma D., Singh A., Trivedi S.S., Bhattacharjee J. Intergenotypic variation of nitric oxide and inflammatory markers in preeclampsia: a pilot study in a North Indian population. Hum Immunol 2011, 72:436-439.
36. Sharma D., Singh A., Trivedi S.S., Bhattacharjee J. Role of endothelin and inflammatory cytokines in pre-eclampsia - a pilot North Indian study. Am J Reprod Immunol 2011, 65:428-432.
37. Arriaga-Pizano L., Jimenez-Zamudio L., Vadillo-Ortega F., Martinez-Flores A., Herrerias-Canedo T., Hernandez-Guerrero C. The predominant Th1 cytokine profile in maternal plasma of preeclamptic women is not reflected in the choriodecidual and fetal compartments. J Soc Gynecol Investig 2005, 12:335-342.
38. Jonsson Y., Ruber M., Matthiesen L., et al. Cytokine mapping of sera from women with preeclampsia and normal pregnancies. J Reprod Immunol 2006, 70:83-91.
39. Chen H.L., Yang Y.P., Hu X.L., Yelavarthi K.K., Fishback J.L., Hunt J.S. Tumor necrosis factor alpha mRNA and protein are present in human placental and uterine cells at early and late stages of gestation. Am J Pathol 1991, 139:327-335.
40. Ellis J., Wennerholm U.B., Bengtsson A., et al. Levels of dimethylarginines and cytokines in mild and severe preeclampsia. Acta Obstet Gynecol Scand 2001, 80:602-608.
41. Dong M., Wang Z., He J. Serum T helper 1- and 2-type cytokines in preeclampsia. Int J Gynaecol Obstet 2005, 89:288-290.
42. Omu A.E., Al-Qattan F., Diejomaoh M.E., Al-Yatama M. Differential levels of T helper cytokines in preeclampsia: pregnancy, labor and puerperium. Acta Obstet Gynecol Scand 1999, 78:675-680.
43. Azizieh F., Raghupathy R., Makhseed M. Maternal cytokine production patterns in women with pre-eclampsia. Am J Reprod Immunol 2005, 54:30-37.
44. Benyo D.F., Smarason A., Redman C.W., Sims C., Conrad K.P. Expression of inflammatory cytokines in placentas from women with preeclampsia. J Clin Endocrinol Metab 2001, 86:2505-2512.
45. Teran E., Escudero C., Moya W., Flores M., Vallance P., Lopez-Jaramillo P. Elevated C-reactive protein and pro-inflammatory cytokines in Andean women with pre-eclampsia. Int J Gynaecol Obstet 2001, 75:243-249.
46. Hayashi M., Ueda Y., Yamaguchi T., et al. Tumor necrosis factor-alpha in the placenta is not elevated in pre-eclamptic patients despite its elevation in peripheral blood. Am J Reprod Immunol 2005, 53:113-119.
47. Velzing-Aarts F.V., Muskiet F.A., van der Dijs F.P., Duits A.J. High serum interleukin-8 levels in Afro-Caribbean women with pre-eclampsia. Relations with tumor necrosis factor-alpha, duffy negative phenotype and von Willebrand factor. Am J Reprod Immunol 2002, 48:319-322.
48. Johnson K., Choi Y., DeGroot E., Samuels I., Creasey A., Aarden L. Potential mechanisms for a proinflammatory vascular cytokine response to coagulation activation. J Immunol 1998, 160:5130-5135.
49. van der Poll T., de Jonge E., Levi M. Regulatory role of cytokines in disseminated intravascular coagulation. Semin Thromb Hemost 2001, 27:639-651.